Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NEOGENOMICS INC Director's Dealing 2014

Dec 1, 2014

32227_dirs_2014-12-01_7643f6d5-07a1-485f-8855-bc0672f79da9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2014-11-26

Reporting Person: CARDOZA GEORGE (Chief Financial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-11-26 Common Stock M 130000 $1.55 Acquired 181089 Direct
2014-11-26 Common Stock S 60000 $4.2795 Disposed 121089 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-11-26 Stock Option (Right to Buy) $1.55 X 130000 Acquired 2014-11-29 Common Stock (0) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 20000 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (Right to buy) $1.46 2016-04-13 Common Stock (0) 100000 Direct
Stock Option (Right to buy) $3.45 2019-03-05 Common Stock (0) 30000 Direct

Footnotes

F1: Exercise of stock options expiring on November 29, 2014, sale to effect cash-less exercise (net of tax).

F2: On November 30, 2009 Mr. Cardoza was granted an option to purchase 150,000 shares. The options were all time based and vested ratably over each of Mr. Cardoza's first four anniversaries with the Company.

F3: On April 14, 2011 Mr. Cardoza was granted an option to purchase 100,000 shares. These options vest ratably at the first four anniversary dates of the grant.

F4: On March 5, 2014 Mr. Cardoza was granted an option to purchase 30,000 shares. These options vest ratably at the first three anniversary dates of the grant.